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Background: Adherence to treatment and the metabolic control of diabetes are challenging 
in many patients with diabetes. The theory of neuroeconomics can provide important clues for 
understanding unreasonable human behavior concerning decisions between outcomes occurring 
at different time points.
Objective: We investigated patients with type 1 and type 2 diabetes to determine whether 
patients who are at a risk of developing complications are less risk averse. We also examined 
whether patients with type 1 and type 2 diabetes have different behavioral traits in decision 
making under risk.
Methods: We conducted a behavioral economics survey of 219 outpatients, 66 with type 1 
diabetes and 153 with type 2 diabetes. All patients had been referred by general practitioners 
or other departments in the hospital. At the time of the survey, levels of hemoglobin A
1c
 were 
not significantly different between patients with type 1 and type 2 diabetes.
Results: Patients with type 2 diabetes showed a lower response rate to the survey compared with 
patients with type 1 diabetes (71.9% vs 87.9%, P,0.01). Logistic regression analysis indicated 
that diabetic retinopathy was negatively associated with risk averse in pricing of hypothetical 
lotteries, myopic time preference, willingness to pay for preventive medicine, and levels of 
satisfaction with life. Diabetic nephropathy was also negatively associated with risk averse in 
pricing of hypothetical lotteries. Detailed analysis revealed that a lower proportion of patients 
with type 2 diabetes (22.7%) were categorized as risk averse compared with patients with type 1 
diabetes (43.1%, P,0.05) in hypothetical lottery risk estimation.
Conclusion: This is the first report that investigated patients with diabetes in a clinical setting 
using a method based on behavioral economics. The results suggest that the attitude of patients 
toward risk plays an important role in the progress of the complications of diabetes. Different 
educational and psychological approaches may be necessary to assess patients with diabetes 
based on whether they have traits such as risk seeking or risk averse.
Keywords: neuroeconomics, hypothetical lottery, risk averse
Introduction
There are two types of diabetes mellitus. Type 1 diabetes is caused by the lack of insulin 
secretion resulting from an autoimmune destruction of insulin-secreting pancreatic β 
cells.1 Management of type 1 diabetes is mainly by exogenous insulin replacement, 
including insulin analogs depending on each patient’s severity of insulin deficiency. 
Type 2 diabetes is initially caused by insulin resistance, which is closely related to the 
accumulation of abdominal fat resulting from overeating, the lack of exercise, relative 
insulin deficiency, first phase insulin defect, and incretin deficiency.2 The standard 
treatment for type 2 diabetes is dietary therapy and appropriate exercise, followed 
by sequential addition of oral antihyperglycemic agents, GLP-1 receptor agonists, or 
insulin injection (basal and/or mealtime).3 Large prospective clinical studies show a 
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strong relationship between glycemia and diabetic micro-
vascular complications in both type 1 and type 2 diabetes.4,5 
However, modification of lifestyle habits, as well as adher-
ence to pharmacological treatment, proves to be challenging 
in many patients.6–8 It remains unclear why many patients 
with diabetes cannot make the necessary lifestyle changes and 
cannot adhere to pharmacological treatment, both of which 
are obviously beneficial for their future health.
The theory of neuroeconomics, an emerging field of study 
dealing with anomalies of the classical economics rationale, 
can provide important clues for understanding unreasonable 
human behavior concerning decisions between outcomes 
occurring at different time points.9 Neuroeconomics studies 
have demonstrated that humans and animals prefer rewards 
with short-term availability over rewards with long-term 
availability.8,9 A recent report by economists investigating 
rational models of addiction indicated that those who empha-
size future rewards and those who give more importance 
to rewards that are certain were significantly more likely to 
continue to abstain from smoking.10 Using an analogy, inves-
tigating personal attitude toward risks may provide important 
information for the treatment of patients with diabetes, espe-
cially for difficult-to-treat patients. However, to date, there 
has been no study analyzing behavior in patients with diabetes 
from a neuroeconomics perspective. In the present study, we 
conducted the first behavioral economics survey of patients 
with type 1 and type 2 diabetes to determine whether patients 
who are at a risk of developing complications are less risk 
averse. On the other hand, in our preliminary study, we found 
that patients with type 2 diabetes with poor glycemic control 
tended to avoid answering questions dealing with decision 
making in hypothetical situations. Therefore, we also examined 
whether patients with type 1 and type 2 diabetes have different 
behavioral traits in terms of decision making under risk.
Patients and methods
All the patients (487 patients) with diabetes treated by an 
endocrinologist at the outpatient clinic of endocrinology 
at Nippon Medical School Chiba Hokusoh Hospital from 
November 2012 to April 2013 were included in this study. The 
hospital is one of three local base hospitals in a rural area of 
Japan with a population of 700,000. The clinic provides care 
to patients with diabetes who have been referred by general 
practitioners or other departments in the hospital because 
of poor metabolic control or unstable complications. Of the 
487 patients, 268 were excluded because of psychiatric dis-
ease, mental retardation, dementia, active malignant disease, 
unstable endocrine disease, or refusal to participate in the sur-
vey. Therefore, 219 outpatients were eligible for the behavioral 
economics survey, 66 with type 1 diabetes and 153 with type 2 
diabetes. Patients with type 1 diabetes were defined as those 
with acute onset of insulin-dependent diabetes or positive anti-
glutamic acid decarboxylase or anti-islet antigen-2 antibodies. 
All other patients were defined as having type 2 diabetes. The 
survey and an explanation sheet that included a consent form 
were handed out at the outpatient clinic. Participants also 
received a book coupon worth 500 yen (JPY 500= USD 5) 
as a token remuneration. The completed survey forms were 
returned by mail. The survey questionnaire used in this study 
is shown in Table 1. The first nine questions were modified 
from the Japan Household Survey on Consumer Preferences 
and Satisfaction (QA–QI),11,12 and the others were developed 
specifically for the present study (QJ–QQ). The HbA
1c
 levels 
were determined by high-performance liquid chromatography 
using HLC723G8 (Tosoh, Co., Tokyo, Japan) and presented 
as the equivalent National Glycohemoglobin Standardization 
Program values. To evaluate retinopathy, ophthalmologists 
performed fundoscopy after pupillary dilatation, based on 
the Davis classification:13 no diabetic retinopathy, simple 
diabetic retinopathy, preproliferative diabetic retinopathy, 
and proliferative diabetic retinopathy, including panretinal 
photocoagulation. Nephropathy was defined as urinary albu-
min excretion $30 mg/g creatinine or estimated glomerular 
filtration rate ,30 mL/min/1.73 m2. The survey results and 
patient data were compared and analyzed. The study protocol, 
including the consent form with a confidentiality clause, was 
approved by the Internal Review Board of the Nippon Medical 
School Chiba-Hokusoh Hospital Ethics Committee.
Statistical analyses
Statistical analyses were performed using JMP® 11 (SAS 
Institute Inc., Cary, NC, USA). Continuous variables were 
compared using the Student’s t-test, Welch’s t-test, or Mann–
Whitney U-test. Stratified comparisons were performed 
using the Mantel–Haenszel procedure. Frequency analysis 
was performed using the Fisher’s exact probability test and 
the McNemar’s chi-square test. The relationship between 
continuous variables was investigated using Spearman’s 
rank correlation coefficient. Multiple logistic regression 




Age-stratified characteristics of patients investigated in this 
study are shown in Table 2. Levels of HbA
1c
 were not signifi-
cantly different between patients with type 1 and type 2 diabetes 
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Behavioral economics survey of diabetic patients
Table 1 survey questionnaires
Question label Construct Text
QA general risk proneness 1 Usually when you go out, how high does the probability of rain have to be before you take an 
umbrella or take a raincoat with you? More than [.....] %.
QB general risk proneness 2 When you have a seat reservation for a train, how many minutes early do you usually arrive  
at the station? [.....] minutes before.
Qc Procrastination 1 (childhood) Thinking about when you were a child and you were given an assignment during school  
vacation, how early did you usually finish up the assignment?
1. i tended to get it done early, before the due date.
2. i worked on it daily, up until the due date.
3. i tended to get it done toward the end.
QD Procrastination 2 (now) Thinking about yourself now, if you were given an assignment during school vacation, how  
early would you finish up the assignment? 
1. i would get it done rather early, before the due date.
2. i would work on it daily, up until the due date.
3. i would get it done rather toward the end.
Qe risk proneness
lottery 1 (low risk, low gain)
suppose that there were a lottery worth 2,000 yen (UsD 20) with a 50% chance of winning.  
What is the most that you would pay for a lottery ticket? i would pay up to [.....] yen.
QF risk proneness
lottery 2 (high risk, high gain)
suppose that there were a lottery worth 100,000 yen (UsD 1,000) with a 1% chance of  
winning. What is the most that you would pay for a lottery ticket? i would pay up to [.....] yen.
Qg endowment effect You happen to find a ticket for a lottery with a 1% chance of winning 100,000 yen  
(UsD 1,000). What’s the lowest price you would sell it for? no less than [.....] yen.
Qh Myopic time preference 1 let’s assume you have two options to receive money. You may choose either receive  
20,000 yen today or to receive a different amount 1 month from today. What is the lowest 
amount of money you would choose to receive 1 month from today, rather than receive 
20,000 yen today. i would wait 1 month to receive the 20,000 yen (UsD 200) if at least [.....] 
yen were added to it.
Qi Myopic time preference 2 how about if the amount you could receive today is 100,000 yen? What is the lowest  
amount of money you would choose to receive 1 month from today, rather than receive  
100,000 yen today.
i would wait 1 month to receive the 100,000 yen (UsD 1,000) if at least [.....] yen were added to it.
QJ Acceptance to uncertainty in  
effectiveness of medicine
A doctor tells you that the effectiveness of the medicine they are prescribing can vary  
among individuals, and that it may or may not end up working for your ailment. Would  
this explanation be sufficient for you?
1. Yes  2. Probably 3. not sure 4. Probably not 5. no
QK Average spending on medical  
care
On average, how much do you spend on medical treatments every month?
Monthly average: [.....] yen.
Ql subjective risk estimation for 
cardiovascular disease (cVD) 
Out of 100 people including yourself, how many of them do you think will have a heart attack 
or stroke within 10 years that makes you think you will also have a heart attack or stroke?
 [.....] people out of 100.
QM Willingness to pay for a medicine  
reducing disease risk
Out of 100 people including yourself, say that 50 of them will have a heart attack or stroke  
within 10 years. A certain kind of medicine can reduce that number to 25. how much would  
you pay every month to continue taking that medicine?
i would pay up to [.....] yen every month just for that medicine.
Qn general satisfaction to  
current life
How satisfied are you with your current life?
1. Very 2. Above average 3. Moderately 4. not much 5. not at all
QO consciousness of disease Do you have diabetes?
1. Yes 2. no 3. not sure
QP Patient understanding of diabetes Which of the following do you think most apply as factors in diabetes getting worse?
1. lifestyle is a greater factor than genetics.
2. lifestyle and genetics are roughly equal factors.
3. genetics are a greater factor than lifestyle.
QQ Family understanding of diabetes The next question is only for diabetes patients.
Does your family tell you that you have diabetes or your diabetes got worse because of  
your lifestyle?
1. Yes 2. Maybe  3. no 4. i do not live with family
in young (under 45 years of age) patients with type 2 diabetes. 
Body mass index (BMI) and prevalence of nephropathy and 
retinopathy were significantly higher in middle-aged (45–under 
65 years of age) patients with type 2 diabetes. Furthermore, in 
young patients, the sex ratio differed between patients with 
type 1 and type 2 diabetes, with more females than males in 
the type 1 diabetes group. Therefore, we performed stratified 
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Table 2 Age-stratified patient characteristics
Type 1 Type 2 P-value
Age under 45
number of patients 32 17
Age (years) 36.3±1.1 37.6±1.5 0.4547
Male:female 10:22 11:6 0.0351
BMi (kg/m2) 23.9±0.8 25.8±1.1 0.1694
Diabetes duration (years) 11.3±1.4 5.6±1.8 0.0173
hbA1c (% ngsP) 7.57±0.23 7.92±0.31 0.3671
nephropathy rate (%) 9.8 23.5 0.1934
retinopathy rate (%) 32.3 29.4 0.8388
insulin treatment (%) 96.8 91.7 0.1870
Age 45–under 65
number of patients 22 76
Age (years) 54.7±1.2 56.8±0.7 0.1280
Male:female 11:11 49:27 0.2198
BMi (kg/m2) 22.7±0.9 26.4±0.5 0.0005
Diabetes duration (years) 10.4±1.3 10.3±0.7 0.9302
hbA1c (% ngsP) 7.48±0.26 7.57±0.14 0.7871
nephropathy rate (%) 13.6 38.2 0.0308
retinopathy rate (%) 18.1 56.8 0.0015
insulin treatment (%) 90.9 60.0 0.0247
Age 65 or older
number of patients 12 60
Age (years) 70.5±1.5 71.5±0.7 0.5399
Male:female 7:5 35:25 1.0000
BMi (kg/m2) 23.7±1.2 24.9±0.6 0.3858
Diabetes duration (years) 20.0±3.1 14.8±1.4 0.1057
hbA1c (% ngsP) 7.49±0.38 7.29±0.16 0.6261
nephropathy rate (%) 43.3 52.4 0.4822
retinopathy rate (%) 33.3 46.5 0.4014
insulin treatment (%) 25.0 43.0 0.2372
Note: Values are presented as mean ± se.
Abbreviations: BMi, body mass index; hbA1c, hemoglobin A1c; ngsP, national 
glycohemoglobin standardization Program; se, standard error.
survey response rate
The survey response rate in patients with type 2 diabetes was 
significantly lower than that in patients with type 1 diabetes 
(71.9% vs 87.9%, Table 3). Age-stratified analysis using 
the Mantel–Haenszel test confirmed that the response rate 
in patients with type 2 diabetes was significantly lower than 
that in patients with type 1 diabetes (P,0.01).
logistic regression analysis of factors 
associated with complications
Before logistic regression analysis, we examined statistical 
correlation between responses to the questionnaires. QE 
(lottery 1 low risk, low gain) and QF (lottery 2 high risk, high 
gain) were significantly correlated (P,0.01). QH (myopic 
time preference 1) was also significantly correlated with 
QI (myopic time preference 2) (P,0.01). Therefore, we 
eliminated QF and QI from the logistic regression analysis 
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Behavioral economics survey of diabetic patients
(procrastination 2) because of apparent correlation with QC 
(procrastination 1).
Table 4 shows the results of logistic regression analysis 
of factors associated with retinopathy. The model produced 
a good fit for the data given the statistical significance of the 
likelihood-ratio chi-square test (P,0.0001). In the standard 
logit results (Wald test), the parameters of diabetes type, 
diabetes duration, levels of HbA
1c
, hypothetical lottery risk 
estimation (low risk, low gain) (QE), myopic time preference 
(QH), willingness to pay for medicine (QM), and levels of 
satisfaction with life (QN) showed statistical significance. 
According to the estimate, type 1, myopic time preference, 
and willingness to pay for a medicine reducing disease risk 
were negatively associated with progression of retinopathy. 
On the other hand, diabetes duration, HbA
1c
, and risk seeking 
(pricing higher) in hypothetical lottery (QE) were positively 
associated with retinopathy. Patients who selected very in 
QE (general satisfaction to current life) had no retinopathy 
or only simple diabetic retinopathy.
Table 5 shows the results of logistic regression analysis 
of factors associated with nephropathy. Nephropathy was 
significantly associated with age, BMI, and risk seeking in 
hypothetical lottery (QE), but not with diabetes type, diabetes 
duration, or levels of HbA
1c
 at the time of the survey.
Attitude toward hypothetical lottery risk 
and type of diabetes
Question QE, which was associated with both retinopathy and 
nephropathy, is a standard question that asks patients about 
certainty equivalents for uncertain benefits.14,15 Questions 
Table 4 Ordinal logistic regression analysisa of factors associated with retinopathy levelsb
Parameter Estimate Standard error Chi-square test P-valuee
Type (type 1) −0.844 0.371 5.16 0.0232f
sex (male) 0.311 0.269 1.33 0.248
Age −0.0122 0.0237 0.27 0.6052
Diabetes duration 0.124 0.0336 13.7 0.0002g
hbA1c
c 0.631 0.219 8.28 0.004g
BMi −0.0566 0.0734 0.59 0.4407
survey responsesd
QA: general risk proneness 1 −0.000605 0.0124 0 0.9611
QB: general risk proneness 2 −0.0106 0.0214 0.25 0.6195
Qc[1]: procrastination 1 −0.508 0.513 0.98 0.3223
Qc[2] 0.998 0.537 3.44 0.0635
Qe: lottery 1 low risk, low gain 0.0000906 0.0000321 7.98 0.0047g
Qg: endowment effect 0.0000114 0.00000869 1.73 0.1884
Qh: myopic time preference 1 −0.0000482 0.0000205 5.52 0.0188f
QJ[2/1]: accept uncertainty −0.794 0.679 1.37 0.2423
QJ[3/2] 0.460 0.789 0.34 0.5602
QJ[4/3] −1.86 1.19 2.43 0.1192
QJ[5/4] 2.97 1.65 3.25 0.0714
QK: medical spending 0.0000361 0.0000278 1.69 0.194
Ql: subjective cVD risk 0.00658 0.0144 0.21 0.6484
QM: willingness to pay −0.0000964 0.0000361 7.11 0.0077g
Qn[2/1]: life satisfaction 5.78 1.46 15.54 ,0.0001g
Qn[3/2] −1.49 0.660 5.1 0.0239f
Qn[4/3] −0.554 0.827 0.45 0.5023
Qn[5/4] 2.04 1.45 1.98 0.1591
QO[1]: DM consciousness 3.35 1,715 0 0.9984
QO[2] −10.9 3,431 0 0.9975
QP[2/1]: patient understanding 0.773 0.589 1.72 0.1895
QP[3/2] 0.466 1.13 0.17 0.6823
QQ[1]: family understanding 3.49 597 0 0.9953
QQ[2] 5.36 597 0 0.9928
QQ[3] 3.60 597 0 0.9952
Notes: aWhole model test: degrees of freedom 31, likelihood-ratio χ2 test 82.79, and P-value ,0.0001. blevels of diabetic retinopathy: 0 nDr, 1 sDr, 2 PPDr, and 3 PDr/
PrP. chbA1c at the time of survey. 
dsurvey questionnaires are shown in Table 1. eWald test for effects. fP,0.05, significant by effect likelihood-ratio test. gP,0.01, significant 
by effect likelihood-ratio test.
Abbreviations: BMi, body mass index; cVD, cardiovascular disease; DM, diabetes mellitus; hbA1c, hemoglobin A1c; nDr, no diabetic retinopathy; sDr, simple diabetic 
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Table 5 nominal logistic regression analysisa of factors associated with nephropathyb
Parameter Estimate Standard error Chi-square test P-valuee
Type (type 1) −0.294 0.391 0.57 0.4516
sex (male) 0.681 0.357 3.63 0.0567
Age 0.0880 0.0305 8.28 0.004g
Diabetes duration 0.0341 0.0378 0.81 0.3676
hbA1c
c −0.00612 0.270 0 0.9819
BMi 0.234 0.0966 5.9 0.0152f
survey responsesd
QA: general risk proneness 1 0.00103 0.0150 0 0.9453
QB: general risk proneness 2 −0.00782 0.0232 0.11 0.7369
Qc[1]: procrastination 1 −0.0149 0.624 0 0.9809
Qc[2] −0.865 0.647 1.78 0.1816
Qe: lottery 1 low risk, low gain 0.0000761 0.0000335 5.15 0.0233f
Qg: endowment effect −0.0000211 0.0000126 2.78 0.0957
Qh: myopic time preference 1 0.00000562 0.0000207 0.07 0.7867
QJ[2/1]: accept uncertainty −1.15 0.743 2.41 0.1205
QJ[3/2] 0.316 0.924 0.12 0.7322
QJ[4/3] 0.590 1.18 0.25 0.6182
QJ[5/4] −1.42 1.82 0.61 0.4331
QK: medical spending −0.0000655 0.0000418 2.46 0.1171
Ql: subjective cVD risk 0.0100 0.0158 0.4 0.5266
QM: willingness to pay −0.0000370 0.0000302 1.5 0.2207
Qn[2/1]: life satisfaction 2.63 1.38 3.62 0.0569
Qn[3/2] 0.0289 0.723 0 0.9681
Qn[4/3] −0.0579 0.976 0 0.9527
Qn[5/4] −1.22 2.40 0.26 0.612
QO[1]: DM consciousness −0.196 140,002 0 1
QO[2] −25.0 221,361 0 0.9999
QP[2/1]: patient understanding −0.633 0.610 1.08 0.2992
QP[3/2] 2.33 1.40 2.77 0.0963
QQ[1]: family understanding −0.348 0.689 0.25 0.6138
QQ[2] 1.40 0.786 3.2 0.0737
QQ[3] −1.39 0.730 3.66 0.0558
Notes: aWhole model test: degrees of freedom 31, likelihood-ratio χ2 test 59.22, P-value 0.0017. bNephropathy was defined as urinary albumin excretion $30 mg/g 
creatinine. chbA1c at the time of survey. 
dsurvey questionnaires are shown in Table 1. eWald test for effects. fP,0.05, significant by effect likelihood ratio test. gP,0.01, 
significant by effect likelihood ratio test.
Abbreviations: BMi, body mass index; cVD, cardiovascular disease; DM, diabetes mellitus; hbA1c, hemoglobin A1c.
QE (lottery 1 low risk, low gain) and QF (lottery 2 high risk, 
high gain) evaluate the ability to accurately understand the 
question and the ability to estimate the risk quantitatively 
(mathematical literacy) and are designed to assess attitudes 
toward risk. Mathematical expectation in both situations is 
1,000 yen (USD 10). The responses to these questions ranged 
widely from 0 yen to 100,000 yen (USD 1,000) in patients 
with type 1 diabetes and from 0 yen to 50,000 yen (USD 500) 
in patients with type 2 diabetes (Figure 1). The mean values 
of patients’ pricing were not significantly different between 
patients with type 1 and type 2 diabetes, but the variances 
were not the same. Therefore, we performed detailed analysis 
of the responses to questions QE and QF comparing type 1 
with type 2 diabetes. Patients who responded #1,000 yen 
(USD 10) to both QE and QF were categorized as risk 
averse. Patients who responded .1,000 yen, do not know, 
or provided no answer were categorized as risk seeking 
or no answer. We also categorized the answer zero as risk 
seeking or no answer, because the answer zero is similar to 
do not know or no answer rather than reflecting strong risk 
aversion.14 The results are shown in Table 6. Frequency 
analysis using Fisher’s exact test revealed that a significantly 
higher proportion of patients with type 1 diabetes were cat-
egorized as risk averse compared with patients with type 2 
diabetes (P,0.05).
Discussion
Over the past two decades, great advances have been made 
in the spectrum of pharmacologic agents and monitor-
ing technology available for the treatment of diabetes.16 
However, the metabolic control of diabetes is still difficult 
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Figure 1 Box plot of responses to question Qe showing quartiles and outliers.
Notes: Qe, lottery 1 low risk, low gain. Type 1, 5,823±2,138 (mean ± se); type 2, 5,064±8,347; difference of the means, Mann–Whitney U-test, P=0.2805; and difference of 
variances, standard F-test, P,0.0001.
Abbreviation: se, standard error.
developing end-stage complications. Hinata et al reported 
that metabolic control in male prisoners with type 2 diabetes 
improved during imprisonment in Japan.17 Although this 
finding demonstrates that intensive lifestyle interventions are 
highly effective for the control of diabetes, it also suggests 
that maintaining a well-regulated lifestyle is difficult in an 
unrestricted person. The behavioral economics approach 
has recently attracted much attention as a possible method 
to improve public health. This approach could be applied 
to the treatment of patients with diabetes. However, some 
investigators are critical of the approach because it has not 
been scientifically supported by solid evidence.18 Although 
there are some reports investigating time preference and 
health behavior in patients with diabetes,19,20 analysis of more 
detailed clinical data is necessary to clarify the trait of health 
behavior in patients with diabetes. This is the first report that 
investigated patients with diabetes in a clinical setting using 
a method based on behavioral economics.
Our survey of patients with diabetes suggests that the 
attitude of patients toward risk is a significant factor in 
the progression of diabetic complications. We found that 
hypothetical lottery risk estimation (QE), myopic time prefer-
ence (QH), willingness to pay for preventive medicine (QM), 
and levels of satisfaction with life (QN) showed statistically 
significant associations with diabetic retinopathy. QN is a 
supplemental question, and it appears reasonable that patients 
with diabetes having complications are not satisfied with their 
life. The results of myopic time preference (QH) appear to 
indicate that patients without retinopathy prefer an immediate 
reward (answering high price to QH). However, it is possible 
that patients considered the question as a choice between 
sure (immediate) gain and uncertain (future) gain, not as 
a temporal discounting.9 The question may not be suitable 
for eliciting information on myopic preference, and further 
studies will be necessary. Willingness to pay for medicine 
appears to be an important factor. One of the new findings 
of this study is that patients with diabetes who are willing to 
pay less for preventive medicine tend to develop retinopathy. 
QC and QD are questions developed by Ikeda et al11,12 and 
are designed to estimate inclination toward procrastination, 
which indicates hyperbolic discounting for future payoffs 
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study, we did not find any association between BMI and QC 
or QD. This discrepancy may reflect the difference between 
the general population and patients with diabetes; however, 
further studies are necessary.
Logistic regression analysis indicated that patients who 
were risk seeking in the estimation of hypothetical lotter-
ies (QE) were prone to develop complications. There are 
several methods to induce risk preference using lotteries, 
including binary lotteries or computerized risk tasks.21–23 
Although these methods are useful for analysis of risk prefer-
ence, they have typically been used to investigate students 
or traders who have a high level of literacy proficiency. 
Our preliminary study revealed that patients with type 2 
diabetes found it difficult to understand these methods. 
Therefore, we used a simple pricing method. Because of the 
free answer method, there was, unexpectedly, a wide range 
of responses to the hypothetical lottery question (Figure 1). 
Some patients suggested that they would pay more for a ticket 
than they could win. Therefore, our results are limited by the 
fact that we could not differentiate patients who were risk 
seeking from those with lower quantitative literacy proficiency. 
On the other hand, recent experimental studies suggest that 
people with low cognitive ability are more likely to engage in 
risky behavior, such as committing crimes and smoking, and 
are more likely to be involved in out-of-wedlock births.10,24 
Therefore, these two factors may be closely related.
As shown in Table 4, type of diabetes (type 1) and risk 
averse in lottery risk estimation (answering low price to QE) 
is negatively associated with retinopathy. Detailed analysis 
of responses to questions QE and QF showed differences 
between patients with type 1 and type 2 diabetes. A lower 
proportion of patients with type 2 diabetes were categorized 
as risk averse compared with patients with type 1 diabetes. 
Patients categorized as risk seeking or no answer included 
both those who had a preference for risk seeking and those 
with lower literacy proficiency, as described in the results 
(attitude toward hypothetical lottery risk and type of diabetes). 
It was suggested that high plasma glucose may affect cogni-
tive function in both type 1 and type 2 diabetes.25,26 Although 
Cavanaugh et al reported that poor numeracy skills were 
common in patients with diabetes,27 they could not compare 
patients with type 1 and type 2 diabetes because of poorer 
glycemic control in patients with type 1 diabetes. In the 
present study, all patients were referred because they were 
difficult to treat, and glycemic control was not significantly 
different between patients with type 1 and type 2 diabetes at 
the time of the survey. Therefore, we could compare patients 
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Behavioral economics survey of diabetic patients
The results suggest the concept that prototypes of type 1 
and type 2 diabetes may be different diseases from the 
perspective of neuroeconomics. Some patients with type 1 
diabetes may have characteristics of neuroeconomics type 2 
or some type 2 patients may be miscategorized as neuroeco-
nomics type 1 by the simplified criteria used in this study. 
Lower quantitative literacy proficiency among patients with 
type 2 diabetes may not be a result of high glucose but a 
reflection of the essential pathophysiology of neuroeconom-
ics type 2 diabetes, for example, insulin resistance. The 
lower response rate among patients with type 2 diabetes may 
be compatible with this hypothesis. Some patients may have 
difficulty in estimating risk mathematically because of low 
literacy proficiency, and it could be that they disregarded 
the survey. Further studies are necessary to investigate this 
hypothesis.
In conclusion, we conducted a behavioral economics 
survey of difficult-to-treat patients with type 1 and type 2 
diabetes. This is the first study to apply a survey used in 
the field of economics to patients with diabetes in a clinical 
setting. Our survey of patients with diabetes suggests that 
the attitude of patients toward risk could be a factor in the 
progression of diabetic complications. We also identified 
significant differences between patients with type 1 and 
type 2 diabetes from the perspective of neuroeconomics. 
Different educational and psychological approaches may be 
necessary in patients with diabetes based on whether they 
are risk seeking or risk averse. On the other hand, the present 
study also highlighted methodological difficulties in behav-
ioral economic surveys of patients with diabetes because 
of low literacy proficiency in some patients. We could not 
differentiate patients who were risk seeking from those with 
low literacy proficiency, although these two factors may be 
closely related. Furthermore, our results demonstrate that 
selection bias is inevitable in almost all surveys of patients 
with diabetes, because those who refuse to participate 
are excluded and not investigated further. Willingness to 
participate in a survey is an important personal trait, and 
selection bias is inevitable in surveys dealing with matters 
related to personal traits. Further studies are necessary to 
establish the most suitable form of the survey for estimation 
of risk preference in patients with diabetes.
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